Impact of primary angioplasty on the indication for implantable cardiac defibrillator in patients with myocardial infarction;Impacto de la angioplastia primaria en la indicación de desfibrilador implantable en pacientes con infarto de miocardio

Revista Espanola de Cardiologia

Volumn 56, Issue 12, 2003, Pages 1182-1186

  González Carrillo, Josefa ^a   García Alberola, Arcadi ^a,b   Saura Espín, Daniel ^a   Carrillo Sáez, Pilar ^a   López Palop, Ramón ^a   Sánchez Muñoz, Juan J ^a   Martínez Sánchez, Juan ^a   Valdés Chávarri, Mariano ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b NONE   (Spain)

Author keywords

Coronary angioplasty; Defibrillator; Myocardial infarction; Tachycardia

Indexed keywords

ACUTE DISEASE; ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; CONTROLLED STUDY; DEFIBRILLATOR; ELECTROCARDIOGRAM; FEMALE; HEALTH PROGRAM; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART STIMULATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPULATION RESEARCH; PREVALENCE; RECORDING; SEX RATIO; STANDARD; SURVIVAL RATE; TREATMENT INDICATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 1642431821     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-8932(03)77036-5     Document Type: Article

References (29)

1. Moss A, Hall J, Cannom D, Daubert J, Higgins S, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk forventricular tachycardia. N Engl J Med 1996;335:1933-40.
2. Buxton A, Lee K, Fisher J, Josephson M, Prystowsky E, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-90.
3. Moss A, Zareba W, Hall W, Klein H, Wilber D, Cannom D, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
4. Bigger J. Expanding indications for implantable cardiac defibrillators. N Engl J Med 2002;346:931-3.
5. Brugada P. La interrupción prematura del estudio MADIT-II: ¿un gran impacto en la economía sanitaria? Rev Esp Cardiol 2002; 55:87-8.
6. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4.
7. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasly compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med 1993;328:685-91.
8. De Boer MJ, Suryapranata H, Hoorntje JC, Reiffers S, Liem AL, Miedema K, et al. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation 1994;90:753-61.
9. Ottervanger J, Van't Hof A, Reiffers S, Hoorntje J, Suryapranata H, De Boer M, et al. Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J 2001;22:726-8.
10. Aguirre FV, Kern MJ, Hsia J, Serota H, Janosik D, Greenwalt T, et al. Importance of myocardial infarct artery patency on the prevalence of ventricular arrhythmia and late potentials after thrombolysis in acute myocardial infarction. Am J Cardiol 1991;68: 1410-6.
11. Hohnloser SH, Franck P, Klingenheben T, Zabel M, Just H. Open infarct artery, late potentials, and other factors in patients after acute myocardial infarction in the thrombolytic era. A prospective trial. Circulation 1994;90:1747-56.
12. De Chillou C, Sadoul N, Bizeau O, Feldman L, Gazakuré E, Ismaïl M, et al. Prognostic value of thrombolysis, coronary artery patency, signal-averaged electrocardiography, left ventricular ejection fraction, and Holter electrocardiographic monitoring for life-threatening, ventricular arrhythmias after a first acute myocardial infarction. Am J Cardiol 1997;80:852-8.
13. ACC/AHA Guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999;100:1016-30.
14. Bigger JT, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984;69:250-8.
15. Mukharji J, Rude RE, Poole WK, Gustafson N, Thomas LJ Jr, Strauss HW, et al. Risk factors for sudden death after acute myocardial infarction: two-year follow-up. Am J Cardiol 1984;54;31-6.
16. Kuchar DL, Thorburn CW, Sammel NL. Prediction of serious arrhythmic events after acute myocardial infarction: signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography. J Am Coll Cardiol 1987;9:531-8.
17. Hohnloser SH, Klingenheben T, Zabel M. Schöpperl M, Mauss O. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1999;33:1895-902.
18. Andresen D, Steinbeck G, Brüggemann T, Müller D, Haberl R, Behrens S, et al. Risk stratification following myocardial infarction in the thrombolytic era. A two-step strategy using noninvasive and invasive methods. J Am Coll Cardiol 1999;33:131-8.
19. Alzueta J, Delclós J, Fernández-Lozano I, Campanyà M, Madrid A. Resultados preliminares del estudio MARS (MADIT and MUSTT Registry Study) [resumen]. Rev Esp Cardiol 2002;55 (Supl 2):78.
20. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-22.
21. Zijlstra F, Hoorntje JC, de Boer MJ, Reiffers S, Miedema K, Ottervanger JP, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999;341:1413-9.
22. Maggioni AP, Zuanetti G, Franzosi MG, Rovelli F, Santoro E, Staszewsky L, et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era GISSI-2 results. Circulation 1993;87: 312-22.
23. Bigger JT, Fleiss JL, Rolnitzky LM. Prevalence, characteristics and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction. Am J Cardiol 1986;58: 1151-60.
24. Andresen D, Bethge KP, Boissel JP, von Leitner ER, Peyrieux JC, Schroder R. et al. Importance of quantitative analysis of ventricular arrhythmias for predicting the prognosis in low-risk postmyocardial infarction patients. European Infarction Study Group. Eur Heart J 1990;11:529-36.
25. De Boer MJ, Reiber JHC, Suryapranata H, van den Brand MJBM, Hoorntje JCA, Zijlstra F. Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction. Eur Heart J 1995;16:1347-55.
26. Pedretti R, Etro MD, Laporta A, Sarzi Braga S, Carù B. Prediction of late arrhythmic events after acute myocardial infarction from combined use of noninvasive prognostic variables and inducibility of sustained monomorphic ventricular tachycardia. Am J Cardiol 1993;71:1131-41.
27. Bhandari AK, Rose JS, Kotlewski A, Rahimtoola SH, Wu D. Frequency and significance of induced sustained ventricular tachycardia or fibrillation two weeks after acute myocardial infarction. Am J Cardiol 1985;56:737-42.
28. Wilber DJ, Olshansky B, Moran JF, Scanlon PJ. Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function. Circulation 1990;82:350-8.
29. Senges JC, Beeker R, Schreiner KD, Bauer A, Weretka S, Siegler K, et al. Variability of Holter electrocardiographic findings in patients fulfilling the noninvasive MADIT criteria. PACE 2002;25: 183-90.